中国中西医结合杂志2011，Vol.31Issue(2)：172-176,5.
复方苦参结肠溶胶囊治疗湿热内蕴型溃疡性结肠炎多中心、随机、双盲、对照研究
A Multi-center Randomized Double-blinded, Placebo-controlled Clinical Study on Efficacy of Composite Sophora Colon-soluble Capsules in Treating Ulcerative Colitis of Internal Dampness-Heat Accumulation Syndrome Type
仝战旗 1杨波 2童新元 3龚琴 2陈丙跃 2吴整军1
作者信息
- 1. 解放军总医院南楼中医针灸科,北京,100853
- 2. 北京中惠药业有限公司,北京,100094
- 3. 解放军总医院医学统计教研室,北京,100853
- 折叠
摘要
Abstract
Objective To evaluate the clinical efficacy and safety of Composite Sophora Colon-soluble Capsules (CSCC) in treating patients with ulcerative colitis (UC) of internal dampness-heat syndrome type (IDHS) and compared with that of Mesalazine slow releasing granules (trade name: Etiasa).Methods Adopting randomized double-blinded double-simulated and positive drug controlled clinical design, 160 patients with UC of IDHS type were randomly assigned to two groups, 120 in the trial group was treated with CSCC plus Etiasa simulated placebo for 8 weeks, while 40 in the control group with Etiasa plus CSCC simulated placebo.Comprehensive therapeutic efficacy, effects on syndrome and safety of treatment were assessed, and changes of endoscopic features, Chinese medical syndrome scores and symptom score, activity index (Al) of UC, microscopic pathology in the two groups were observed and compared before and after treatment.Results After 8-week treatment, the clinical total effective rate in the two groups were 92.0％ and 83.3％, the effective rate on Chinese medical syndrome in them were 91.7％ and 85.0％, that on endoscopic features 92.0％ and 83.3％, on microscopic changes 66.7％and 52.0％, respectively, showing insignificant difference between groups.Difference between groups in Al also showed no significance (1.03 ±1.87 vs 1.78 ±2.18, P＞0.05).However, the effects of decreasing Chinese medical syndrome score, and improving mucous pus blood stool and foul defecation in the trial group were more significantly (P ＜0.05).No serious adverse event was seen in the 8-week treatment period.Conclusions The clinical efficacy of CSCC was not inferior to, or even better than that of Etiasa.It could be taken as a substitute of chemicals if with poor effect.关键词
复方苦参结肠溶胶囊/美沙拉嗪缓释颗粒/溃疡性结肠炎/湿热内蕴证/多中心临床试验引用本文复制引用
仝战旗,杨波,童新元,龚琴,陈丙跃,吴整军..复方苦参结肠溶胶囊治疗湿热内蕴型溃疡性结肠炎多中心、随机、双盲、对照研究[J].中国中西医结合杂志,2011,31(2):172-176,5.
